BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 33961993)

  • 1. Cross-talk between next generation sequencing methodologies to identify genomic signatures of esophageal cancer.
    Verma R; Sattar RSA; Nimisha ; Apurva ; Kumar A; Sharma AK; Sumi MP; Ahmad E; Ali A; Mahajan B; Saluja SS
    Crit Rev Oncol Hematol; 2021 Jun; 162():103348. PubMed ID: 33961993
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genomic characterization of esophageal squamous cell carcinoma: Insights from next-generation sequencing.
    Sasaki Y; Tamura M; Koyama R; Nakagaki T; Adachi Y; Tokino T
    World J Gastroenterol; 2016 Feb; 22(7):2284-93. PubMed ID: 26900290
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel candidate genes may be possible predisposing factors revealed by whole exome sequencing in familial esophageal squamous cell carcinoma.
    Forouzanfar N; Baranova A; Milanizadeh S; Heravi-Moussavi A; Jebelli A; Abbaszadegan MR
    Tumour Biol; 2017 May; 39(5):1010428317699115. PubMed ID: 28459198
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miRNA-mRNA crosstalk in esophageal cancer: From diagnosis to therapy.
    Sharma P; Sharma R
    Crit Rev Oncol Hematol; 2015 Dec; 96(3):449-62. PubMed ID: 26257289
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genome Sequencing in Esophageal Squamous Cell Carcinoma.
    Pillai S; Maksemous N; Lam AK
    Methods Mol Biol; 2020; 2129():217-240. PubMed ID: 32056181
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characteristics and response to next-generation sequencing-guided therapy in locally advanced or metastatic esophageal cancer.
    Ma Y; Li W; Chen S; Lin S; Ding S; Zhou X; Liu T; Wang R; Wang W
    Int J Cancer; 2023 Feb; 152(3):436-446. PubMed ID: 36214796
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of serum CYFRA 21-1 concentrations in patients with esophageal cancer.
    Brockmann JG; St Nottberg H; Glodny B; Sprakel B; Senninger N
    Anticancer Res; 2000; 20(6D):4899-904. PubMed ID: 11332443
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Somatic mutations in plasma cell-free DNA are diagnostic markers for esophageal squamous cell carcinoma recurrence.
    Ueda M; Iguchi T; Masuda T; Nakahara Y; Hirata H; Uchi R; Niida A; Momose K; Sakimura S; Chiba K; Eguchi H; Ito S; Sugimachi K; Yamasaki M; Suzuki Y; Miyano S; Doki Y; Mori M; Mimori K
    Oncotarget; 2016 Sep; 7(38):62280-62291. PubMed ID: 27556701
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [High throughput-targeted sequencing panel for exploring radiosensitivity associated genes in esophageal squamous cell carcinoma].
    Qiao Y; Hu CX; Song DA; Li SQ; Zhou LH; Jiang XD
    Zhonghua Zhong Liu Za Zhi; 2017 Aug; 39(8):584-588. PubMed ID: 28835080
    [No Abstract]   [Full Text] [Related]  

  • 10. Comprehensive Genomic Profiling of Advanced Esophageal Squamous Cell Carcinomas and Esophageal Adenocarcinomas Reveals Similarities and Differences.
    Wang K; Johnson A; Ali SM; Klempner SJ; Bekaii-Saab T; Vacirca JL; Khaira D; Yelensky R; Chmielecki J; Elvin JA; Lipson D; Miller VA; Stephens PJ; Ross JS
    Oncologist; 2015 Oct; 20(10):1132-9. PubMed ID: 26336083
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Noninvasive diagnosis and monitoring of mutations by deep sequencing of circulating tumor DNA in esophageal squamous cell carcinoma.
    Luo H; Li H; Hu Z; Wu H; Liu C; Li Y; Zhang X; Lin P; Hou Q; Ding G; Wang Y; Li S; Wei D; Qiu F; Li Y; Wu S
    Biochem Biophys Res Commun; 2016 Mar; 471(4):596-602. PubMed ID: 26876573
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeted next-generation sequencing of commonly mutated genes in esophageal adenocarcinoma patients with long-term survival.
    Visser E; Franken IA; Brosens LAA; de Leng WWJ; Strengman E; Offerhaus JA; Ruurda JP; van Hillegersberg R
    Dis Esophagus; 2017 Sep; 30(9):1-8. PubMed ID: 28859360
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeted next generation sequencing identified clinically actionable mutations in patients with esophageal sarcomatoid carcinoma.
    Lu H; Yang S; Zhu H; Tong X; Xie F; Qin J; Han N; Wu X; Fan Y; Shao YW; Mao W
    BMC Cancer; 2018 Mar; 18(1):251. PubMed ID: 29506494
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Copy number alterations detected by whole-exome and whole-genome sequencing of esophageal adenocarcinoma.
    Wang X; Li X; Cheng Y; Sun X; Sun X; Self S; Kooperberg C; Dai JY
    Hum Genomics; 2015 Sep; 9(1):22. PubMed ID: 26374103
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA Genome Sequencing in Esophageal Adenocarcinoma.
    Pillai S; Gopalan V; Lam AK
    Methods Mol Biol; 2018; 1756():231-246. PubMed ID: 29600374
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic Alterations in Esophageal Tissues From Squamous Dysplasia to Carcinoma.
    Liu X; Zhang M; Ying S; Zhang C; Lin R; Zheng J; Zhang G; Tian D; Guo Y; Du C; Chen Y; Chen S; Su X; Ji J; Deng W; Li X; Qiu S; Yan R; Xu Z; Wang Y; Guo Y; Cui J; Zhuang S; Yu H; Zheng Q; Marom M; Sheng S; Zhang G; Hu S; Li R; Su M
    Gastroenterology; 2017 Jul; 153(1):166-177. PubMed ID: 28365443
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PIK3CA mutation is a favorable prognostic factor in esophageal cancer: molecular profile by next-generation sequencing using surgically resected formalin-fixed, paraffin-embedded tissue.
    Yokota T; Serizawa M; Hosokawa A; Kusafuka K; Mori K; Sugiyama T; Tsubosa Y; Koh Y
    BMC Cancer; 2018 Aug; 18(1):826. PubMed ID: 30115035
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CYFRA 21-1 determination in patients with esophageal squamous cell carcinoma: clinical utility for detection of recurrences.
    Kawaguchi H; Ohno S; Miyazaki M; Hashimoto K; Egashira A; Saeki H; Watanabe M; Sugimachi K
    Cancer; 2000 Oct; 89(7):1413-7. PubMed ID: 11013352
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genomic profiling of esophageal squamous cell carcinoma (ESCC)-Basis for precision medicine.
    Yang JW; Choi YL
    Pathol Res Pract; 2017 Jul; 213(7):836-841. PubMed ID: 28554745
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Lung cancer molecular testing, what role for Next Generation Sequencing and circulating tumor DNA].
    Pécuchet N; Legras A; Laurent-Puig P; Blons H
    Ann Pathol; 2016 Jan; 36(1):80-93. PubMed ID: 26803564
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.